Descripción del proyecto
Un biotejido innovador a medida para el ámbito sanitario
Los biotejidos biomédicos a base de seda se han utilizado ampliamente en el sector clínico. A la hora de formar fibras, las sedas naturales presentan una eficiencia y sostenibilidad significativamente superiores a las de los polímeros sintéticos. Un aquamelt de seda es un nanocompuesto de materia biológica que se produce a través del proceso de hilado que realizan arañas y gusanos de seda. Este material combina resistencia, tenacidad, utilidad y seguridad. El proyecto SAM, financiado con fondos europeos, tiene como objetivo introducir en el mercado médico aquamelts de seda hechos a medida para obtener soluciones sanitarias innovadoras. SAM ofrecerá un sustituto del plástico sin organismos genéticamente modificados, ni sustancias químicas tóxicas y con agua como único subproducto.
Objetivo
Silk Aquamelts to Market (SAM) will catalyse the process of bringing Spintex Engineering’s silk aquamelts, as high-performance artificially spun fibres, to the medical market. SAM aims to fully commercialise our bespoke silks, for novel healthcare solutions. Objective 1 starts with a market analysis of medical biotextiles and their patent landscape. A dedicated research analyst will identify networking, commercial and regulatory opportunities/challenges for our company’s novel and unmatched fibres. Sharing the results of this work, the market analysis will provide a detailed feasibility study for silk aquamelts in the biotextiles sector, assisting further developments from FLIPT members and their own roadmapping work which is currently textile focused. By focusing on healthcare SAM will target a market with attractive profit margins, and demonstrate the viability of the aquamelt pathway in a heavily regulated industry. Objective 2 will tackle this regulatory compliance and certification in Good Manufacturing Practice (GMP), and ISO 10993 & 13485 for our silk aquamelts. By training key personnel in compliance with ISO standards and GMP, audit certification with EU notified bodies and receipt of CE marks will be achieved and individuals upskilled. We will demonstrate silk aquamelts’ utility and safety and add value to FLIPT, by expanding the opportunities available for other aquamelt materials and assisting their route to market. Furthermore, contact with investors, customers and at conferences, will establish the aquamelt pathway as the future of EU fibre production. This will directly benefit the uptake of future aquamelt developments from the FLIPT project and help several key work packages and tasks.
Ámbito científico
Programa(s)
Convocatoria de propuestas
Consulte otros proyectos de esta convocatoriaConvocatoria de subcontratación
H2020-FETOPEN-2018-2019-2020-03
Régimen de financiación
CSA - Coordination and support actionCoordinador
OX5 2DH Oxford
Reino Unido
Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.